Optometry Times

📢 June Issue Alert! The latest edition of Optometry Times is out now. Stay ahead with the latest research and insights in the field of optometry. Access the June 2024 issue here: https://bit.ly/3XA1CF9

Sherrol A. Reynolds, OD, gives insight into her highlights from this year's National Optometric Association (NOA) Convention, which shone a spotlight on advocating for visual health for minority populations, in an exclusive interview with Optometry Times. Watch the interview: https://lnkd.in/eV4tAp6F

Whether seeing or non-seeing, prosthetic eye patients should be treated from the chair the same as patients without prosthetics, according to Philip Aitseboamo, OD, PhD. He outlines his talk, "Ocular Prosthetics for Seeing and Non-seeing Eye," which he presented at the National Optometric Association Convention this year, in an interview with Optometry Times. Watch the interview: https://lnkd.in/e6Jw6nxU

OKYO Pharma has announced its plan to advance OK-101 into a phase 2 clinical trial of neuropathic corneal pain, expected to begin in Q3 of 2024. The announcement of this trial follows the FDA clearance of the Investigational New Drug (IND) application of OK-101 for neuropathic corneal pain back in February. OK-101 is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune cells of the eye responsible for the inflammatory response. Read more: https://lnkd.in/eVJj6YSY

Catch up on this week's developments from your favorite optometric publication here: https://lnkd.in/eQy4yxFc

With myopia remaining one of the hottest topics in optometry, educating patients and optometric staff alike on treatment options and slowing progression. According to Ashley Wallace-Tucker, OD, FAAO, FSLS, ABO Dipl, looking to the future of treatment and management can inform what optometric staff can do in the present. “I recommend having the patient come back in six months, just for maybe your check in, and just assess what’s going on there and then have the conversation again,” she said. “Then at the year mark, have the conversation again.” Read more: https://lnkd.in/emcthbiY

Boston researchers led by first author Jimena Tatiana Hathaway, MD, MPH, reported that there is a potential risk of the development of non-arteritic ischemic optic neuropathy (NAION) associated with prescriptions for semaglutide (Wegovy, Ozempic, Novo Nordisk). Prescriptions with semaglutide are FDA approved to treat obesity and type 2 diabetes, respectively. Hathaway is from the Harvard T.H. Chan School of Public Health, and the Department of Ophthalmology, and Neuro-Ophthalmology Service Massachusetts Eye and Ear, Harvard Medical School, all in Boston. Read more: https://lnkd.in/eT7w9_M3

"Artificial intelligence (AI) is now everywhere—not just in our day-to-day lives but also in the rapidly evolving landscape of health care technology. It is making significant strides in creating efficiencies at home, in the car, in schools, and at our doctor appointments. In the health care space, with the promise of enhancing the efficiency of clinical documentation in our electronic health record (EHR) systems, it can have a significant positive impact not only on the quality of patient care but also on the satisfaction of its doctor users," writes Kiranjeet Sran, OD. Read more: https://lnkd.in/eSpNUm3b

We are excited to invite you to EyeCon 2024 in Fort Lauderdale, FL! This premier event is tailored for ophthalmologists and optometrists eager to stay ahead in eye care. Join us for insightful presentations on the latest advancements, invaluable networking opportunities, and explore cutting-edge technologies and innovations in our exhibit hall. 🚨 Early Bird Pricing Ends August 1, 2024 🚨 Don't miss out on the savings—register now and secure your spot. We look forward to welcoming you to Fort Lauderdale and advancing the future of eye care together! 👉 Register today: https://ow.ly/KNiQ50SyMox

The American Board of Opticianry and National Contact Lens Examiners (ABO & NCLE) and the National Federation of Opticianry Schools (NFOS) have announced the formation of the United Opticians Association (UOA), a new international organization for spectacle and contact lens optician professionals. The organization also works to connect national organizations, including the Opticians Association of America (OAA), with the ABO & NCLE and NFOS, according to a news release. Read more: https://lnkd.in/eA8jBd2n